Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Clinical trial NCT01644643 · COMPLETED

Trial details

NCT number: NCT01644643
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Complicated Urinary Tract Infection Complicated Intra-abdominal Infection

Start date: 2013-01-01
Primary completion: 2014-09-01
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.